Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis

Molecular Biology of the Cell

Volumn 10, Issue 1, 1999, Pages 23-33

  Dell'Era, Patrizia ^a   Mohammadi, Moosa ^b   Presta, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; MUTANT PROTEIN; TYROSINE; UROKINASE RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL LINE; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; MITOGENESIS; MYOBLAST; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

EID: 0032923028     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.1.23     Document Type: Article

References (59)

1. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., and Saltiel, A.R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
2. Basilico, C., and Moscatelli, D. (1992). The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-165.
3. Bastaki, M., Nelli, E.E., Dell'Era P., Rusnati, M., Molinari-Tosatti, M.P., Parolini, S., Auerbach, R., Ruco, L.P., Possati, L., and Presta, M. (1997). Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. Arterioscler. Thromb. Vasc. Biol. 17, 454-464.
4. Besser, D., Presta, M., and Nagamine, Y. (1995). Elucidation of a signalling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 6, 1009-1017.
5. Blaikie, P., Immanuel, D., Wu, J., Li, N., Yajnik, V., and Margolis, B. (1994). A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J. Biol. Chem. 269, 32031-32034.
6. Blasi, F., and Verde, P. (1990). Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol. 1, 117-126.
7. Bork, P., and Margolis, B. (1995). A phosphotyrosine interaction domain. Cell 80, 693-694.
8. Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. (1991). Oncogenes and signal transduction. Cell 64, 281-302.
9. Chellaiah, A.T., McEwen, D.G., Werner, S., Xu, J., and Ornitz, D.M. (1994). Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem. 269, 11620-11627.
10. Chen, C., and Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
11. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
12. Coltrini, D., Gualandris, A., Nelli, E.E., Parolini, S., Molinari-Tosatti, M.P., Quarto, N., Ziehe, M., Giavazzi, R., and Presta, M. (1995). Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. Cancer Res. 55, 4729-4738.
13. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R., and Lee, J.C. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233.
14. Dano, K., Andreasen, P.A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L.S., and Skriver, L. (1985). Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44, 139-266.
15. Dionne, C.A., Crumley, G., Bellot, F., Kaplow, J.M., Searfoss, G., Ruta, M., Burgess, W.H., Jaye, M., and Schlessinger, J. (1990). Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9, 2685-2692.
16. Fantl, W.J., Johnson, D.E., and Williams, L.T. (1993). Signalling by receptor tyrosine kinases. Annu. Rev. Biochem. 62, 453-481.
17. Faris, M., Ensoli, B., Stahl, N., Yancopoulos, G., Nguyen, A., Wang, S., and Nel, A.E. (1996). Differential activation of the extracellular signal-regulated kinase, jun kinase and janus kinase-stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells. AIDS 10, 369-378.
18. Gaffen, S.L., Lai, S.Y., Ha, M., Liu, X., Hennighausen, L., Greene, W.C., and Goldsmith, M.A. (1996). Distinct tyrosine residues within the interleukin-2 receptor β chain drive signal transduction specificity, redundancy, and diversity. J. Biol. Chem. 271, 21381-21390.
19. Gob, K.C., Lim, Y.P., Ong, S.H., Siak, C.B., Cao, X., Tan, Y.H., and Guy, G.R. (1996). Identification of p90, a prominent tyrosine-phosphorylated protein in fibroblast growth factor-stimulated cells, as 80K-H. J. Biol. Chem. 271, 5832-5838.
20. Huang, J., Mohammadi, M., Rodrigues, G.A., and Schlessinger, J. (1995). Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem. 270, 5065-5072.
21. Ido, M., Nagao, Y., Higashigawa, M., Shibata, T., Taniguchi, K.X., Hamazaki M, and Sakurai, M. (1991). Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells. Br. J. Cancer 64, 1103-1107.
22. Isacchi, A., Statuto, M., Chiesa, R., Bergonzoni, L., Rusnati, M., Sarmientos, P., Ragnotti, G., and Presta, M. (1991). A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc. Natl. Acad. Sci. USA 88, 2628-2632.
23. Johnson, D.E., Lu, J., Chen, H., Werner, S., and Williams, L.T. (1991). The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell. Biol. 11, 4627-4634.
24. Johnson, D.E., and Williams, L.T. (1993). Structural and functional diversity in the FGF receptor multigene family. [Review]. Adv. Cancer Res. 60, 1-41.
25. Kavanaugh, W.M., Turck, C.W., and Williams, L.T. (1995). PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 268, 1177-1179.
26. Kavanaugh, W.M., and Williams, L.T. (1994). An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266, 1862-1865.
27. Kouhara, H., Hadari, Y.R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I., and Schlessinger, J. (1997). A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/ MAPK signaling pathway. Cell 89, 693-702.
28. Kwaan, H.C. (1992) The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev. 11, 291-311.
29. Keegan, K., Johnson, D.E., Williams, L.T., and Hayman, M.J. (1991). Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA 88, 1095-1099.
30. Koch, C.A., Anderson, D., Moran, M.F., Ellis, C., and Pawson, T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674.
31. Lee, P.L., Johnson, D.E., Cousens, L.S., Fried, V.A., and Williams, L.T. (1989). Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245, 57-60.
32. Lin, H.Y., Xu, J., Ischenko, I., Ornitz, D.M., Halegoua, S., and Hayman, M.J. (1998). Identification of the cytoplasmic regions of fibroblast growth factor (FGF) receptor 1 which play important roles in induction of neurite outgrowth in PC12 cells by FGF-1. Mol. Cell. Biol. 18, 3762-3770.
33. Margolis, B. (1992). Proteins with SH2 domains: transducers in the tyrosine kinase signaling pathway. Cell Growth Differ. 3, 73-80.
34. Mohammadi, M., Dionne, C.A., Li, W., Li, N., Spivak, T., Honegger, A.M., Jaye, M., and Schlessinger, J. (1992). Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358, 681-684.
35. Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W.H., Jaye, M., and Schlessinger, J. (1996a). Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16, 977-989.
36. Mohammadi, M., Honegger, A.M., Rotin, D., Fischer, R., Bellot, F., Li, W., Dionne, C.A., Jaye, M., Rubinstein, M., and Schlessinger, J. (1991). A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (fig) is a binding site for the SH2 domain of phospholipase C-γ1. Mol. Cell. Biol. 11, 5068-5078.
37. Mohammadi, M., Schlessinger, J., and Hubbard, S.R. (1996b). Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86, 577-587.
38. Mori, S., Ronnstrand, L., Yokote, K., Engstrom, A., Courtneidge, S.A., Claesson-Welsh, L., and Heldin, C.H. (1993). Identification of two juxtamembrane autophosphorylation sites in the PFGD beta-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J. 12, 2257-2264.
39. Obermeier, A., Bradshaw, R.A., Seedorf, K., Choidas, A., Schlessinger, J., and Ullrich, A. (1994). Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J. 13, 1585-1590.
40. Ornitz, D.M., Xu, J., Colvin, J.S., McEwen, D.G., MacArthur, C.A., Coulier, F., Gao, G., and Goldfarb, M. (1996). Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292-15297.
41. Partanen, J., Mäkelä, T.P., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L., and Alitalo, K. (1991). FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10, 1347-1354.
42. Pawson, T. (1995). Protein modules and signalling networks. Nature (Lond.) 373, 573-580.
43. Pawson, T., and Schlessinger, J. (1993). SH2 and SH3 domains. Curr. Biol. 3, 434-442.
44. Peters, K.G., Marie, J., Wilson, E., Ives, H.E., Escobedo, J., Del Rosario, M., Mirda, D., and Williams, L.T. (1992). Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Nature 358, 678-681.
45. Presta, M., Gualandris, A., Urbinati, C., Rusnati, M., Coltrini, D., Isacchi, A., Caccia, P., and Bergonzoni, L. (1993). Subcellular localization and biological activity of M(r) 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence. Growth Factors 9, 269-278.
46. Presta, M., Maier, J.A., and Ragnotti, G. (1989). The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J. Cell Biol. 109, 1877-1884.
47. Presta, M., Maier, J.A., Rusnati, M., Moscatelli, D., and Ragnotti, G. (1988). Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta. Cancer Res. 48, 6384-6389.
48. Presta, M., Statuto, M., Isacchi, A., Caccia, P., Pozzi, A., Gualandris, A., Rusnati, M., Bergonzoni, L., and Sarmientos, P. (1992). Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. Biochem. Biophys. Res. Commun. 185, 1098-1107.
49. Roghani, M., Mohammadi, M., Schlessinger, J., and Moscatelli, D. (1996). Induction of urokinase-type plasminogen activator by fibroblast growth factor (FGF)-2 is dependent on expression of FGF receptors and does not require activation of phospholipase Cγ1. J. Biol. Chem. 271, 31154-31159.
50. Rusnati, M., Dell'Era, P., Urbinati, C., Tanghetti, E., Massardi, M.L., Nagamine, Y., Monti, E., and Presta, M. (1996). A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells. Mol. Biol. Cell 7, 369-381.
51. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
52. Spivak-Kroizman, T., Mohammadi, M., Hu, P., Jaye, M., Schlessinger, J., and Lax, I. (1994). Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. J. Biol. Chem. 269, 14419-14423.
53. Tienari, J., Alanko, T., Lehtonen, E., and Saksela, O. (1991). The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells. Cell Regul. 2, 285-297.
54. Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 205-212.
55. Wang, J.-K., Xu, H., Li, H.-C., and Goldfarb, M. (1996). Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. Oncogene 13, 721-729.
56. Ward, C.W., Gough, K.H., Rashke, M., Wan, S.S., Tribbick, G., and Wang, J. (1996). Systematic mapping of potential binding sites for She and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. J. Biol. Chem. 271, 5603-5609.
57. Wennstrom, S., Landgren, E., Blume-Jensen, P., and Claesson-Welsh, L. (1992). The platelet-derived growth factor beta-receptor kinase insert confers specific signaling properties to a chimeric fibroblast growth factor receptor. J. Biol. Chem. 267, 13749-13756.
58. White, M.F., Livingston, J.N., Backer, J.M., Lauris, V., Dull, T.J., Ullrich, A., and Kahn, C.R. (1988). Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54, 641-649.
59. Xu, H., Lee, K.W., and Goldfarb, M. (1998). Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins. J. Biol. Chem. 273, 17987-17990.